Endocannabinoids are released after brain injury and believed to attenuate neuronal
damage by binding to CB 1 receptors and protecting against excitotoxicity. Such excitotoxic …

Anxiety disorders are one of the most common mental health problems worldwide, but the
exact pathophysiology remains largely unknown. It has been demonstrated previously that …

Abstract The amphetamine-related drug 3, 4methylenedioxymethamphetamine (MDMA) is
known to induce neurotoxic damage in dopaminergic regions of the mouse brain. In order to …

Alzheimer's disease (AD) is characterized by memory impairment, neurochemically by
accumulation of β-amyloid peptide (namely Aβ1-42) and morphologically by an initial loss of …

Cerebral ischemia causes tissue death owing to occlusion of the cerebral blood vessels,
and cerebral ischemia activates mitogen-activated protein kinase (MAPK) and induces …

Tau is a microtubule-associated protein, and the oligomeric and hyperphosphorylated forms
of tau are increased significantly after neurotrauma and considered important factors in …

Maternal separation (MS) is an early life stress model that induces permanent changes in
the central nervous system, impairing hippocampal long-term potentiation (LTP) and spatial …

3, 4-Methylenedioxymethamphetamine (MDMA)(“Ecstasy”) produces neurotoxic effects,
which result into an impairment of learning and memory and other neurological …

Abstract Adenosine A2A receptor (A2AR) antagonism attenuates 1‐methyl‐4‐phenyl‐1, 2, 3,
6‐tetrahydropyridine‐induced dopaminergic neurodegeneration and quinolinic acid …

Acute administration of repeated doses of 3, 4‐methylenedioxymethamphetamine (MDMA,
ecstasy) dramatically reduces striatal dopamine (DA) content, tyrosine hydroxylase (TH) …